Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Feb 13;8(3):815-816.
doi: 10.1182/bloodadvances.2023011842.

A leap in recognizing drug-induced immune hemolytic anemia

Dennis Lund Hansen  1   2 , Henrik Frederiksen  1   2
Affiliations
Editorial

A leap in recognizing drug-induced immune hemolytic anemia

Dennis Lund Hansen et al. Blood Adv. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest disclosure: The authors declare no competing financial interests with this commentary or the study commented on. Outside of the study, D.L.H. declares research grants from Alexion and Novartis; conference fee from EUSA Pharma, and Alexion; and advisory board membership for Takeda and Janssen. H.F. declares project grants from Novartis, Alexion, Sanofi, and Gilead for research unrelated to this study; and honoraria from Sanofi and Alexion for lectures on thrombotic microangiopathies.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. Maquet J, Lafaurie M, Michel M, Lapeyre-Mestre M, Moulis G. Drug-induced immune hemolytic anemia: detection of new signals and risk assessment in a Nationwide Cohort Study. Blood Adv. 2024;8(3):817–826. - PMC - PubMed
    1. Aster RH, Bougie DW. Drug-induced immune thrombocytopenia. N Engl J Med. 2007;357(6):580–587. - PubMed
    1. Marini I, Uzun G, Jamal K, Bakchoul T. Treatment of drug-induced immune thrombocytopenias. Haematologica. 2022;107(6):1264–1277. - PMC - PubMed
    1. Arndt PA. Drug-induced immune hemolytic anemia: the last 30 years of changes. Immunohematology. 2014;30(2):44–54. - PubMed
    1. Garbe E, Andersohn F, Bronder E, et al. Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study. Br J Haematol. 2011;154(5):644–653. - PubMed